SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-073779
Filing Date
2020-06-16
Accepted
2020-06-16 16:26:48
Documents
14
Period of Report
2020-06-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2022696-1_8k.htm   iXBRL 8-K 29614
2 EXHIBIT 99.1 tm2022696d1_ex99-1.htm EX-99.1 6456
3 GRAPHIC tm2022696d1_ex99-1img001.jpg GRAPHIC 2250
  Complete submission text file 0001104659-20-073779.txt   214793

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA gild-20200614.xsd EX-101.SCH 3180
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE gild-20200614_lab.xml EX-101.LAB 34591
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gild-20200614_pre.xml EX-101.PRE 22706
12 EXTRACTED XBRL INSTANCE DOCUMENT tm2022696-1_8k_htm.xml XML 3496
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES INC (Filer) CIK: 0000882095 (see all company filings)

IRS No.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19731 | Film No.: 20966758
SIC: 2836 Biological Products, (No Diagnostic Substances)